Skip to main content

Blood Borne Infections in Hemophiliacs in a Developing Country. A Single Center Experience

  • Conference paper
36th Hemophilia Symposium Hamburg 2005

Conclusions

NBP are still a factor of concern in patients with hemophilia despite the more efficient screening methods introduced in the last decade in our country. From this perspective, clotting factor concentrates are much more efficient and safe, but the limited access to them in our patients makes imperative to use the combination with CPP or FFP.Mandatory vaccination against HBV and the introduction of serological screening methods for donors in Romania after 1993 has led to the decrease of the risk for hepatitis transmission.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adamowicz-Salach A, Pawelek K, Loch T, Zdzieblowska-Pawinska A, Brojer E, Walewska-Zielecka, Rokicka-Milewska R. Incidence and treatment of hepatitis C virus infection in children with haemophilia in Poland. Haemophilia, 1999, 5, 436–440

    Article  PubMed  CAS  Google Scholar 

  2. Giangrande P.L.F.nvCJD and Blood Products in the UK. Scharrer I, Schramm W., (Ed), 35th Haemophilia Symposium Hamburg 2004, Springer, 29–32

    Google Scholar 

  3. Gürtler L.G. Update on the Safety of Clotting Factors, Mainly Regarding the Risk of Transmission of vCJD (Variant Creutzfeldt Jakob Disease). Scharrer I, Schramm W. (Ed.), 35th Haemophilia Symposium Hamburg 2004, Springer, 21–29

    Google Scholar 

  4. Farrugia A. Evolving perspectives in product safety for haemophilia.Haemophilia, 2002, 8, 236–243

    Article  PubMed  CAS  Google Scholar 

  5. Ragni MV, Belle SH. Coinfection with hepatitis C virus and HIV in hemophilic men. J.Infect.Dis.,2001,183(7), 1112–1115

    Article  PubMed  CAS  Google Scholar 

  6. Sabin CA, Emery V, Devereux HL, Griffioen A, Bishop J, Dusheiko G, Yee TT, Herrero-Martinez E, Lee CA. HCV-RNA levels in patients with bleeding disorders. J.Med..Virol. 2002,68(1),68–75

    Article  PubMed  CAS  Google Scholar 

  7. Sousi J.M., Richardson LC. Risk factors for infection with HBV and HCV in a large cohort of hemophiliac males. Transfusion,2001,41(3),338–343

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Verlag Berlin Heidelberg

About this paper

Cite this paper

Serban, M. et al. (2007). Blood Borne Infections in Hemophiliacs in a Developing Country. A Single Center Experience. In: Scharrer, I., Schramm, W. (eds) 36th Hemophilia Symposium Hamburg 2005. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-36715-4_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-36715-4_28

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-36714-7

  • Online ISBN: 978-3-540-36715-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics